| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 06/21/2000 | DE19858777A1 Complete separation of glycosylated protein from non-glycosylated proteins uses immobilized triazin dye as a separation agent and proteins are eluted in stages by raising ionic capacity or pH |
| 06/21/2000 | CN1257078A Technology for extracting squid protamine |
| 06/20/2000 | US6077951 Glycosylhydrazines preparation immobilization and reactions of glycoprotein analysis and O-glycan removal |
| 06/20/2000 | US6077940 Free solution ligand interaction molecular separation method |
| 06/20/2000 | US6077939 Methods and kits for making polypeptides having a single covalently bound N-terminal water-soluble polymer |
| 06/20/2000 | US6077935 Unglycosylated viral polypeptide; for the detection of viral antigens in human blood; for vaccine development |
| 06/20/2000 | US6077507 Method of making a composition comprising a fibrin monomer |
| 06/20/2000 | CA1341030C Protein active in humoral hypercalcemia of malignancy-pthrp |
| 06/20/2000 | CA1341029C Peptidase inhibitors |
| 06/17/2000 | CA2292474A1 Process for dissolving albumin flakes in a liquid and arrangement for carrying out the process |
| 06/15/2000 | WO2000034784A1 Protein scaffolds for antibody mimics and other binding proteins |
| 06/15/2000 | WO2000034505A1 Expression system for factor viii |
| 06/15/2000 | WO2000034317A2 Method for reducing immunogenicity of proteins |
| 06/15/2000 | WO2000034315A2 Purification of echinocandin cyclopeptide compounds |
| 06/15/2000 | WO2000034313A1 Procollagen c-proteinase inhibitors |
| 06/15/2000 | WO2000034312A1 Method of separating basic peptide or basic protein |
| 06/15/2000 | WO2000034311A1 Method for improving solubility of protein |
| 06/15/2000 | WO2000034236A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE |
| 06/15/2000 | WO2000033881A1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative |
| 06/15/2000 | WO2000033865A1 Methods of inhibiting ectopic calcification |
| 06/15/2000 | WO2000011023A3 Ring modified cyclic peptide analogs |
| 06/15/2000 | WO2000003011A3 METHOD FOR PRODUCING A PEPTIDE WITH A pI ABOVE 8 OR BELOW 5 |
| 06/15/2000 | CA2354868A1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative |
| 06/15/2000 | CA2354547A1 Method for improving solubility of protein |
| 06/15/2000 | CA2354189A1 Methods of inhibiting ectopic calcification |
| 06/15/2000 | CA2354142A1 Reversible aqueous ph sensitive lipidizing reagents, compositions and methods of use |
| 06/15/2000 | CA2353930A1 Purification of echinocandin cyclopeptide compounds |
| 06/15/2000 | CA2352740A1 Procollagen c-proteinase inhibitors |
| 06/15/2000 | CA2351346A1 Protein scaffolds for antibody mimics and other binding proteins |
| 06/15/2000 | CA2342967A1 Modifying protein immunogenicity |
| 06/14/2000 | EP1008572A1 Method for inferring protein functions with the use of ligand data base |
| 06/14/2000 | EP1008355A1 Method for identifying or analyzing polymer linkage sites on macromolecules using amino acid report binding |
| 06/14/2000 | EP1007969A1 Lithographic mask design and synthesis of diverse probes on a substrate |
| 06/14/2000 | EP1007718A1 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying |
| 06/14/2000 | EP1007699A1 Peptide-enhanced transfections |
| 06/14/2000 | EP1007666A1 Neurturin receptor |
| 06/14/2000 | EP1007647A1 High level of expression of ingap |
| 06/14/2000 | EP1007557A1 Bactericidal/permeability-increasing protein: crystallization, x-ray diffraction, three-dimensional structure determination, rational drug design and |
| 06/14/2000 | EP1007554A1 Oil bodies and associated proteins as affinity matrices |
| 06/14/2000 | EP1007542A1 Improved method for c-terminal degradaton of peptides and proteins |
| 06/14/2000 | EP1007541A1 Randomly generated glycopeptide combinatorial libraries |
| 06/14/2000 | EP1007537A1 Receptor protein designated 2f1 |
| 06/14/2000 | EP1007106A1 Combinatorial library |
| 06/14/2000 | EP1007095A2 Chimeric toxins for targeted therapy |
| 06/14/2000 | EP1007065A1 Preparation of collagen |
| 06/14/2000 | EP0853612B1 Alpha-hydrazino acid derivatives and method for making same |
| 06/14/2000 | EP0710243B1 Synthesis of cyclic peptides |
| 06/14/2000 | EP0677057B1 Biopolymer synthesis utilizing surface activated, organic polymers |
| 06/13/2000 | US6075141 N.sup.α -α, α-dimethyl-3,5-dialkoxybenzylcarbonyl amino acid 3,4-dihydro-3-hydroxy-4-oxo-1,2,3-benzotriazin-3-yl and pentafluorophenyl esters |
| 06/13/2000 | US6075127 Adjusting polypeptide or peptide for efficient purification; inserting cleavable methionine and histidine tag at the end of polypeptide or peptide chain and preventing cleavage at interior methionine by the presence of sulfoxide groups |
| 06/13/2000 | US6075122 A peptide for the detection, monitoring, and treatment of cancer in animals; anticarciongenic agents |
| 06/13/2000 | US6075121 Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such |
| 06/13/2000 | CA2157196C Inhibitors of herpes viral ribonucleotide reductase |
| 06/13/2000 | CA2036398C Hiv protease inhibiting agents |
| 06/13/2000 | CA1341026C Il-1 inhibitors process for producing il-1 inhibitors and for using such inhibitors in therapy |
| 06/13/2000 | CA1341023C Peptide derivatives |
| 06/08/2000 | WO2000033084A2 Arrays of organic compounds attached to surfaces |
| 06/08/2000 | WO2000032814A2 Methods for producing selected interstrand cross-links in nucleic acids and applications thereof |
| 06/08/2000 | WO2000032542A1 Carriers for combinatorial compound libraries |
| 06/08/2000 | WO2000032235A1 Transport system conjugate |
| 06/08/2000 | WO2000012541A3 Cytotoxic peptides modified by bulky or lipophilic moieties |
| 06/08/2000 | WO2000012536A3 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 06/08/2000 | CA2353643A1 Methods for producing selected interstrand cross-links in chromosomal nucleic acids and applications thereof |
| 06/08/2000 | CA2352555A1 Transport system conjugate |
| 06/07/2000 | EP1006200A2 Methods for producing selected interstrand cross-links in nucleic acids and applications thereof |
| 06/07/2000 | EP1006199A1 Applications with and methods for producing selected interstrand crosslinks in nucleic acid |
| 06/07/2000 | EP1005655A2 Method of drug selection |
| 06/07/2000 | EP1005492A1 Purification of von willebrand factor by cation exchanger chromatography |
| 06/07/2000 | EP1005491A1 Modified cytokine receptor protein |
| 06/07/2000 | EP1005372A1 Anti-cd40l immunotoxins for the treatment of diseases |
| 06/07/2000 | CN1255504A Process for directly enriching nerve growth factor from raw venin |
| 06/07/2000 | CN1255503A Process for purifying nerve growth factor from venin |
| 06/07/2000 | CN1053197C Extracting process for flammulin essence |
| 06/07/2000 | CN1053195C Method for extracting chicken nucleic acid and nucleoprotein from chicken blood |
| 06/06/2000 | US6072075 Trisubstituted n-protected guanidines |
| 06/06/2000 | US6072045 Chimeric isoprenoid synthases and uses thereof |
| 06/06/2000 | US6072039 Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest |
| 06/06/2000 | US6071885 Administering a cardiac glycosides and aglycone derivatives to inhibit export of leaderless proteins into extracellular spaces; useful in treatment of tumors and diabetes |
| 06/06/2000 | US6071705 Method of detecting neurological disease or dysfunction |
| 06/06/2000 | US6071538 Oral delivery composition comprising supramolecular complex |
| 06/06/2000 | US6071532 Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof |
| 06/06/2000 | CA1341014C Hcg peptides for use in antibody purification procedures |
| 06/02/2000 | WO2000031547A1 Prion protein standard and method of making same |
| 06/02/2000 | WO2000031279A2 Producing antimicrobial cationic peptides as fusion proteins |
| 06/02/2000 | WO2000031119A1 Method for producing l-prolyl-l-m-sarcolysyl-l-p-fluorophenylalanine and derivatives thereof |
| 06/02/2000 | WO2000031116A1 Method for continuously isolating active proteins |
| 06/02/2000 | WO2000031115A1 Methods of identifying antigen gene sequences |
| 06/02/2000 | WO2000031114A1 DNA ENCODING PROTEINS THAT INHIBIT Hsp70 FUNCTION |
| 06/02/2000 | WO2000031102A1 Oligonucleotide conjugation |
| 06/02/2000 | WO2000030425A2 Method of using pon-1 to decrease atheroma formation |
| 06/02/2000 | WO2000012587A3 Polyamide chains of precise length, methods to manufacture them and their conjugates |
| 06/02/2000 | WO2000011030A3 Method for chromatographically purifying insulins |
| 06/02/2000 | CA2351737A1 Efficient methods for producing antimicrobial cationic peptides in host cells |
| 06/02/2000 | CA2351736A1 Methods of identifying antigen gene sequences |
| 06/02/2000 | CA2351408A1 Method for producing l-prolyl-l-m-sarcolysyl-l-p-fluorophenylalanine and derivatives thereof |
| 06/02/2000 | CA2350405A1 Method of using pon-1 to decrease atheroma formation |
| 06/02/2000 | CA2350215A1 Method for continuously isolating active proteins |
| 06/02/2000 | CA2349337A1 Prion protein standard and method of making same |
| 05/31/2000 | EP1004323A1 Method for producing immunoglobulin preparations |
| 05/31/2000 | EP1004322A2 Technetium-99m labeled peptides for thrombus imaging |